MeSH tree: C14.907.077
Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier-stage kidney cancers in ...
Jun 16, 2026
0
5
A newly published review from the Kennedy Krieger Institute highlights major progress in developing biomarkers to improve the diagnosis and treatment of Sturge-Weber syndrome (SWS).
Aug 26, 2025
0
10
Port wine stains—capillary malformations on the skin—are the most visible manifestation of Sturge-Weber syndrome. However, up to 60% of babies with birthmarks in high-risk locations (forehead and upper eyelid) also have capillary ...
Jun 27, 2024
0
101
Researchers at Kennedy Krieger Institute and Boston Children's Hospital have discovered a new way to decrease early seizure likelihood and improve neurologic outcomes among infants with Sturge-Weber Syndrome (SWS). This collaboration ...
Jan 12, 2024
0
44
A research team at the Francis Crick Institute and Great Ormond Street Hospital (GOSH)/UCL Great Ormond Street Institute of Child Health have identified new potential treatments for children with rare genetic conditions of ...
Oct 4, 2023
0
58
The most comprehensive study of kidney cancer at single-cell level has discovered a potential drug target to treat renal cell carcinoma, a cancer with a high mortality rate that is hard to detect. Researchers from the Wellcome ...
Nov 25, 2022
0
854
Considerable progress has been made to improve, extend, and save lives of patients with cancer in the last year, according to the 12th annual Cancer Progress Report released by the American Association for Cancer Research ...
Sep 21, 2022
0
22
